QA: Seelos Therapeutics INC in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001017491_2020_Seelos_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001017491, Seelos Therapeutics INC

  xvar xval
0 AssetsCurrent 11,096,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 10,778,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 325,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 7,408,959
9 ResearchAndDevelopmentExpense 19,274,200
10 remainder_Expenses 0
11 remainder_Revenues 243,409
12 remainder_NetIncome -57,236,152
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 11,096,000
1 Liabilities 11,103,000
2 Expenses 26,683,159
3 Revenues 243,409
4 StockholdersEquity -7,000
5 NetIncome -83,675,902
6 ComprehensiveNetIncome -83,675,902
7 BaseVar 53,180,860
8 EconomicCapitalRatiobeforeLimitedLiability -7.54
9 EconomicCapitalRatio 0.0149

Edgar->Model Mapping

Feature Distribution

Change over Time